Mostrar el registro sencillo del ítem

dc.contributor.author
Irazola, Vilma  
dc.contributor.author
Gutierrez, Laura  
dc.contributor.author
Bloomfield, Gerald  
dc.contributor.author
Carrillo-Larco, Rodrigo M.  
dc.contributor.author
Dorairaj, Prabhakaran  
dc.contributor.author
Gaziano, Thomas  
dc.contributor.author
Levitt, Naomi S.  
dc.contributor.author
Miranda, J. Jaime  
dc.contributor.author
Ortiz, Antonio Bernabe  
dc.contributor.author
Steyn, Krisela  
dc.contributor.author
Wu, Yangfeng  
dc.contributor.author
Xavier, Denis  
dc.contributor.author
Yan, Lijing L.  
dc.contributor.author
He, Jiang  
dc.contributor.author
Rubinstein, Adolfo Luis  
dc.date.available
2019-12-02T21:05:01Z  
dc.date.issued
2016-03  
dc.identifier.citation
Irazola, Vilma; Gutierrez, Laura; Bloomfield, Gerald; Carrillo-Larco, Rodrigo M.; Dorairaj, Prabhakaran; et al.; Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities Results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases; Elsevier; Global Heart; 11; 1; 3-2016; 47-59  
dc.identifier.issn
2211-8160  
dc.identifier.uri
http://hdl.handle.net/11336/91137  
dc.description.abstract
Background Hypertension is the leading cause of cardiovascular disease and premature death worldwide. The prevalence of this public health problem is increasing in low- and middle-income countries (LMICs) in both urban and rural communities. Objective The aim of this study was to examine hypertension prevalence, awareness, treatment, and control in adults 35 to 74 years of age from urban and rural communities in LMICs in Africa, Asia, and South America. Methods The authors analyzed data from 7 population-based cross-sectional studies in selected communities in 9 LMICs that were conducted between 2008 and 2013. Age- and sex-standardized prevalence rates of pre-hypertension and hypertension were calculated. The prevalence rates of awareness, treatment, and control of hypertension were estimated overall and by subgroups of age, sex, and educational level. Results In selected communities, age- and sex-standardized prevalence rates of hypertension among men and women 35 to 74 years of age were 49.9% (95% confidence interval [CI]: 42.3% to 57.4%) in Kenya, 54.9% (95% CI: 51.3% to 58.4%) in South Africa, 52.5% (95% CI: 50.1% to 54.8%) in China, 32.5% (95% CI: 31.7% to 33.3%) in India, 42.3% (95% CI: 40.4% to 44.2%) in Pakistan, 45.4% (95% CI: 43.6% to 47.2%) in Argentina, 39.9% (95% CI: 37.8% to 42.1%) in Chile, 19.2% (95% CI: 17.8% to 20.5%) in Peru, and 44.1% (95% CI: 41.6% to 46.6%) in Uruguay. The proportion of awareness varied from 33.5% in India to 69.0% in Peru, the proportion of treatment among those who were aware of their hypertension varied from 70.8% in South Africa to 93.3% in Pakistan, and the proportion of blood pressure control varied from 5.3% in China to 45.9% in Peru. Conclusions The prevalence of hypertension varies widely in different communities. The rates of awareness, treatment, and control also differ in different settings. There is a clear need to focus on increasing hypertension awareness and control in LMICs.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
HYPERTENSION  
dc.subject
PREVALENCE  
dc.subject
TREATMENT  
dc.subject
CONTROL  
dc.subject.classification
Epidemiología  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Hypertension Prevalence, Awareness, Treatment, and Control in Selected LMIC Communities Results from the NHLBI/UHG Network of Centers of Excellence for Chronic Diseases  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2019-11-26T19:56:09Z  
dc.identifier.eissn
2211-8179  
dc.journal.volume
11  
dc.journal.number
1  
dc.journal.pagination
47-59  
dc.journal.pais
Estados Unidos  
dc.description.fil
Fil: Irazola, Vilma. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Gutierrez, Laura. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.description.fil
Fil: Bloomfield, Gerald. Duke Clinical Research Institute; Estados Unidos  
dc.description.fil
Fil: Carrillo-Larco, Rodrigo M.. Cronicas Centro de Excelencia En Enfermedades Crónicas; Perú  
dc.description.fil
Fil: Dorairaj, Prabhakaran. Public Health Foundation Of India; India. Centre For Chronic Disease Control; India  
dc.description.fil
Fil: Gaziano, Thomas. Harvard University. Harvard School of Public Health; Estados Unidos. Brigham And Women's Hospital; Estados Unidos  
dc.description.fil
Fil: Levitt, Naomi S.. University Of Cape Town; Sudáfrica  
dc.description.fil
Fil: Miranda, J. Jaime. Universidad Peruana Cayetano Heredia; Perú. Cronicas Centro de Excelencia En Enfermedades Crónicas; Perú  
dc.description.fil
Fil: Ortiz, Antonio Bernabe. Cronicas Centro de Excelencia En Enfermedades Crónicas; Perú  
dc.description.fil
Fil: Steyn, Krisela. University Of Cape Town; Sudáfrica  
dc.description.fil
Fil: Wu, Yangfeng. Peking University; China  
dc.description.fil
Fil: Xavier, Denis. St. John's Medical College; India  
dc.description.fil
Fil: Yan, Lijing L.. Peking University; China. Duke Kunshan University; China  
dc.description.fil
Fil: He, Jiang. University of Tulane; Estados Unidos  
dc.description.fil
Fil: Rubinstein, Adolfo Luis. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Instituto de Efectividad Clínica y Sanitaria; Argentina  
dc.journal.title
Global Heart  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2211816015003130  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.gheart.2015.12.008